Leader
|
|
|
00000nz a2200037n 45 0 |
001
|
|
|
WKP|Q86385629
(VIAF cluster)
(Authority/Source Record)
|
003
|
|
|
WKP |
005
|
|
|
20241221010735.0 |
008
|
|
|
241221nneanz||abbn n and d |
035
|
|
|
‡a
(WKP)Q86385629
|
024
|
|
|
‡a
0000-0002-2841-5502
‡2
orcid
|
024
|
|
|
‡a
6506502483
‡2
scopus
|
035
|
|
|
‡a
(OCoLC)Q86385629
|
100
|
0 |
|
‡a
Francisco Javier López Román
‡c
researcher
‡9
en
|
400
|
0 |
|
‡a
Francisco Javier López Román
‡c
wetenschapper
‡9
nl
|
670
|
|
|
‡a
Author's Assessing the Validity of the MyJump2 App for Measuring Different Jumps in Professional Cerebral Palsy Football Players: An Experimental Study
|
670
|
|
|
‡a
Author's COMBINED INTRAVITREAL RANIBIZUMAB AND ORAL SUPPLEMENTATION WITH DOCOSAHEXAENOIC ACID AND ANTIOXIDANTS FOR DIABETIC MACULAR EDEMA: Two-Year Randomized Single-Blind Controlled Trial Results.
|
670
|
|
|
‡a
Author's Digestion-resistant maltodextrin effects on colonic transit time and stool weight: a randomized controlled clinical study
|
670
|
|
|
‡a
Author's Dissociable Effects of Executive Load on Perceived Exertion and Emotional Valence during Submaximal Cycling
|
670
|
|
|
‡a
Author's [Effect of quinua
|
670
|
|
|
‡a
Author's Effect of quinua (Chenopodium quinoa)consumption as a coadjuvant in nutritional intervention in prediabetic subjects
|
670
|
|
|
‡a
Author's Effects of Two Community-Based Exercise Programs on Adherence, Cardiometabolic Markers, and Body Composition in Older People with Cardiovascular Risk Factors: A Prospective Observational Cohort Study
|
670
|
|
|
‡a
Author's Muscle damage and inflammation biomarkers after two ultra-endurance mountain races of different distances: 54 km vs 111 km
|
670
|
|
|
‡a
Author's Muscle damage, physiological changes, and energy balance in ultra-endurance mountain-event athletes.
|
670
|
|
|
‡a
Author's Oxidative Stress in Endurance Cycling Is Reduced Dose-Dependently after One Month of Re-Esterified DHA Supplementation
|
670
|
|
|
‡a
Author's Pomegranate Extract Improves Maximal Performance of Trained Cyclists after an Exhausting Endurance Trial: A Randomised Controlled Trial
|
670
|
|
|
‡a
Author's Re-esterified DHA improves ventilatory threshold 2 in competitive amateur cyclists
|
670
|
|
|
‡a
Author's Supplementation of Re-Esterified Docosahexaenoic and Eicosapentaenoic Acids Reduce Inflammatory and Muscle Damage Markers after Exercise in Endurance Athletes: A Randomized, Controlled Crossover Trial
|
670
|
|
|
‡a
Author's THREE-YEAR OUTCOMES IN A RANDOMIZED SINGLE-BLIND CONTROLLED TRIAL OF INTRAVITREAL RANIBIZUMAB AND ORAL SUPPLEMENTATION WITH DOCOSAHEXAENOIC ACID AND ANTIOXIDANTS FOR DIABETIC MACULAR EDEMA.
|
670
|
|
|
‡a
Author's What Pelvic Floor Muscle Training Load is Optimal in Minimizing Urine Loss in Women with Stress Urinary Incontinence? A Systematic Review and Meta-Analysis
|
909
|
|
|
‡a
(scopus) 6506502483
‡9
1
|
909
|
|
|
‡a
(orcid) 0000000228415502
‡9
1
|
919
|
|
|
‡a
effectsof2communitybasedexerciseprogramsonadherencecardiometabolicmarkersandbodycompositioninolderpeoplewithcardiovascularriskfactorsaprospectiveobservationalcohortstudy
‡A
Effects of Two Community-Based Exercise Programs on Adherence, Cardiometabolic Markers, and Body Composition in Older People with Cardiovascular Risk Factors: A Prospective Observational Cohort Study
‡9
1
|
919
|
|
|
‡a
assessingthevalidityofthemyjump2appformeasuringdifferentjumpsinprofessionalcerebralpalsyfootballplayersanexperimentalstudy
‡A
Assessing the Validity of the MyJump2 App for Measuring Different Jumps in Professional Cerebral Palsy Football Players: An Experimental Study
‡9
1
|
919
|
|
|
‡a
combinedintravitrealranibizumabandoralsupplementationwithdocosahexaenoicacidandantioxidantsfordiabeticmacularedema2yearrandomizedsingleblindcontrolledtrialresults
‡A
COMBINED INTRAVITREAL RANIBIZUMAB AND ORAL SUPPLEMENTATION WITH DOCOSAHEXAENOIC ACID AND ANTIOXIDANTS FOR DIABETIC MACULAR EDEMA: Two-Year Randomized Single-Blind Controlled Trial Results.
‡9
1
|
919
|
|
|
‡a
digestionresistantmaltodextrineffectsoncolonictransittimeandstoolweightarandomizedcontrolledclinicalstudy
‡A
Digestion-resistant maltodextrin effects on colonic transit time and stool weight: a randomized controlled clinical study
‡9
1
|
919
|
|
|
‡a
dissociableeffectsofexecutiveloadonperceivedexertionandemotionalvalenceduringsubmaximalcycling
‡A
Dissociable Effects of Executive Load on Perceived Exertion and Emotional Valence during Submaximal Cycling
‡9
1
|
919
|
|
|
‡a
whatpelvicfloormuscletrainingloadisoptimalinminimizingurinelossinwomenwithstressurinaryincontinenceasystematicreviewandmetaanalysis
‡A
What Pelvic Floor Muscle Training Load is Optimal in Minimizing Urine Loss in Women with Stress Urinary Incontinence? A Systematic Review and Meta-Analysis
‡9
1
|
919
|
|
|
‡a
3yearoutcomesinarandomizedsingleblindcontrolledtrialofintravitrealranibizumabandoralsupplementationwithdocosahexaenoicacidandantioxidantsfordiabeticmacularedema
‡A
THREE-YEAR OUTCOMES IN A RANDOMIZED SINGLE-BLIND CONTROLLED TRIAL OF INTRAVITREAL RANIBIZUMAB AND ORAL SUPPLEMENTATION WITH DOCOSAHEXAENOIC ACID AND ANTIOXIDANTS FOR DIABETIC MACULAR EDEMA.
‡9
1
|
919
|
|
|
‡a
supplementationofreesterifieddocosahexaenoicandeicosapentaenoicacidsreduceinflammatoryandmuscledamagemarkersafterexerciseinenduranceathletesarandomizedcontrolledcrossovertrial
‡A
Supplementation of Re-Esterified Docosahexaenoic and Eicosapentaenoic Acids Reduce Inflammatory and Muscle Damage Markers after Exercise in Endurance Athletes: A Randomized, Controlled Crossover Trial
‡9
1
|
919
|
|
|
‡a
reesterifieddhaimprovesventilatorythreshold2incompetitiveamateurcyclists
‡A
Re-esterified DHA improves ventilatory threshold 2 in competitive amateur cyclists
‡9
1
|
919
|
|
|
‡a
pomegranateextractimprovesmaximalperformanceoftrainedcyclistsafteranexhaustingendurancetrialarandomisedcontrolledtrial
‡A
Pomegranate Extract Improves Maximal Performance of Trained Cyclists after an Exhausting Endurance Trial: A Randomised Controlled Trial
‡9
1
|
919
|
|
|
‡a
oxidativestressinendurancecyclingisreduceddosedependentlyafter1monthofreesterifieddhasupplementation
‡A
Oxidative Stress in Endurance Cycling Is Reduced Dose-Dependently after One Month of Re-Esterified DHA Supplementation
‡9
1
|
919
|
|
|
‡a
effectofquinua
‡A
[Effect of quinua
‡9
1
|
919
|
|
|
‡a
muscledamagephysiologicalchangesandenergybalanceinultraendurancemountaineventathletes
‡A
Muscle damage, physiological changes, and energy balance in ultra-endurance mountain-event athletes.
‡9
1
|
919
|
|
|
‡a
muscledamageandinflammationbiomarkersafter2ultraendurancemountainracesofdifferentdistances54kmvs111km
‡A
Muscle damage and inflammation biomarkers after two ultra-endurance mountain races of different distances: 54 km vs 111 km
‡9
1
|
919
|
|
|
‡a
effectofquinuachenopodiumquinoaconsumptionasacoadjuvantinnutritionalinterventioninprediabeticsubjects
‡A
Effect of quinua (Chenopodium quinoa)consumption as a coadjuvant in nutritional intervention in prediabetic subjects
‡9
1
|
996
|
|
|
‡2
ISNI|0000000013766524
|
996
|
|
|
‡2
DNB|1104405628
|
996
|
|
|
‡2
RERO|A009629597
|
996
|
|
|
‡2
ISNI|0000000003100577
|
996
|
|
|
‡2
BNE|XX5640027
|
996
|
|
|
‡2
BNE|XX6521645
|
996
|
|
|
‡2
BNCHL|10000000000000000013477
|
996
|
|
|
‡2
NTA|234576804
|
996
|
|
|
‡2
RERO|A012447492
|
996
|
|
|
‡2
SUDOC|25847226X
|
996
|
|
|
‡2
BNE|XX1568386
|
996
|
|
|
‡2
J9U|987011196882205171
|
996
|
|
|
‡2
LC|n 85819609
|
996
|
|
|
‡2
NII|DA14397795
|
996
|
|
|
‡2
SUDOC|115990283
|
996
|
|
|
‡2
NTA|130271853
|
996
|
|
|
‡2
BNE|XX1007939
|
996
|
|
|
‡2
DNB|12484930X
|
996
|
|
|
‡2
ISNI|000000044438910X
|
996
|
|
|
‡2
LC|ns2015000104
|
996
|
|
|
‡2
LC|no2010026882
|
996
|
|
|
‡2
PTBNP|87906
|
996
|
|
|
‡2
BNC|981058610466406706
|
996
|
|
|
‡2
BNE|XX5368436
|
996
|
|
|
‡2
NTA|070302367
|
996
|
|
|
‡2
BNC|981058513292106706
|
996
|
|
|
‡2
SUDOC|261037722
|
996
|
|
|
‡2
BNCHL|10000000000000000084009
|
996
|
|
|
‡2
NLA|000036203079
|
996
|
|
|
‡2
BNF|14597071
|
996
|
|
|
‡2
LC|no2008072102
|
996
|
|
|
‡2
NUKAT|nx2022761621
|
996
|
|
|
‡2
ICCU|CFIV246735
|
996
|
|
|
‡2
SUDOC|270271848
|
996
|
|
|
‡2
DNB|141205679
|
996
|
|
|
‡2
LC|no2014083164
|
996
|
|
|
‡2
LC|no 92009038
|
996
|
|
|
‡2
BNC|981058520281106706
|
996
|
|
|
‡2
PLWABN|9811544629605606
|
996
|
|
|
‡2
LC|n 93029797
|
996
|
|
|
‡2
BNF|17158560
|
996
|
|
|
‡2
BAV|495_303841
|
996
|
|
|
‡2
BNE|XX1017503
|
996
|
|
|
‡2
NII|DA17359668
|
996
|
|
|
‡2
DNB|132690322
|
996
|
|
|
‡2
ISNI|0000000115572739
|
996
|
|
|
‡2
ISNI|0000000061347455
|
996
|
|
|
‡2
BNE|XX5139952
|
996
|
|
|
‡2
ISNI|0000000081582217
|
996
|
|
|
‡2
BNE|XX1096249
|
996
|
|
|
‡2
JPG|500065468
|
996
|
|
|
‡2
LIH|LNB:V-125915;=BJ
|
996
|
|
|
‡2
LC|n 97008276
|
996
|
|
|
‡2
DNB|1267039981
|
996
|
|
|
‡2
CAOONL|ncf10962380
|
996
|
|
|
‡2
BNE|XX1067699
|
996
|
|
|
‡2
NTA|356246744
|
996
|
|
|
‡2
NSK|000604287
|
996
|
|
|
‡2
RERO|A006447714
|
996
|
|
|
‡2
DNB|114718254X
|
996
|
|
|
‡2
ISNI|0000000436147012
|
996
|
|
|
‡2
SUDOC|076515087
|
996
|
|
|
‡2
DNB|1023666642
|
996
|
|
|
‡2
BNC|981058616110306706
|
996
|
|
|
‡2
PLWABN|9810682679405606
|
996
|
|
|
‡2
LC|no2014165738
|
996
|
|
|
‡2
DNB|1310681600
|
996
|
|
|
‡2
NUKAT|n 97005839
|
996
|
|
|
‡2
JPG|500084125
|
996
|
|
|
‡2
DNB|128379316
|
996
|
|
|
‡2
BNCHL|10000000000000000293655
|
996
|
|
|
‡2
BIBSYS|90968265
|
996
|
|
|
‡2
BNF|17916786
|
996
|
|
|
‡2
SUDOC|15842588X
|
996
|
|
|
‡2
BNE|XX1430476
|
996
|
|
|
‡2
DNB|1203584687
|
996
|
|
|
‡2
ISNI|0000000468828605
|
996
|
|
|
‡2
J9U|987007574448705171
|
996
|
|
|
‡2
SUDOC|230796141
|
996
|
|
|
‡2
ISNI|0000000133789309
|
996
|
|
|
‡2
BNF|16245465
|
996
|
|
|
‡2
RERO|A025740575
|
996
|
|
|
‡2
ISNI|0000000020649836
|
996
|
|
|
‡2
LC|n 2016068653
|
996
|
|
|
‡2
SUDOC|241839173
|
996
|
|
|
‡2
ISNI|0000000493366553
|
996
|
|
|
‡2
DNB|1157618367
|
996
|
|
|
‡2
BNE|XX1036567
|
996
|
|
|
‡2
SUDOC|245196366
|
996
|
|
|
‡2
ISNI|0000000385094968
|
996
|
|
|
‡2
BNE|XX5633151
|
996
|
|
|
‡2
ISNI|0000000113078198
|
996
|
|
|
‡2
PLWABN|9811570438905606
|
996
|
|
|
‡2
ISNI|0000000106559698
|
996
|
|
|
‡2
BNE|XX1673629
|
996
|
|
|
‡2
BNE|XX843788
|
997
|
|
|
‡a
0 0 lived 0 0
‡9
1
|